Immediate Impact
67 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
Notch signaling pathway in cancer: from mechanistic insights to targeted therapies
2024 Standout
Works of Vincent Houé being referenced
Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial
2016
A multicenter open-label phase II study of the efficacy and safety of ganitumab (AMG 479), a fully human monoclonal antibody against insulin-like growth factor type 1 receptor (IGF-1R) as second-line therapy in patients with recurrent platinum-sensitive ovarian cancer.
2013
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Vincent Houé | 56 | 88 | 78 | 75 | 15 | 273 | |
| Brian L. Heiss | 42 | 86 | 97 | 16 | 15 | 276 | |
| Yasuhiro Shinagawa | 8 | 39 | 44 | 57 | 11 | 305 | |
| Tine Descamps | 73 | 115 | 12 | 98 | 20 | 316 | |
| Silvia Carbonell‐Morote | 40 | 29 | 55 | 19 | 27 | 313 | |
| Yichen Cheng | 31 | 66 | 31 | 17 | 10 | 221 | |
| Michelle DeVeaux | 40 | 53 | 21 | 12 | 13 | 244 | |
| Fengyi Qu | 21 | 16 | 74 | 17 | 21 | 226 | |
| Qian‐Zhi Ni | 33 | 35 | 44 | 7 | 17 | 208 | |
| Anica M. Wandler | 9 | 26 | 43 | 23 | 15 | 266 | |
| A Collet | 20 | 100 | 25 | 6 | 16 | 267 |
All Works
Loading papers...